Largest biotech by earnings

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Gilead Sciences leads the 24 biotech ranked by earnings, at $8.5B, ahead of Amgen ($7.7B) and Biogen ($1.3B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead Sciences$8.5B
Median
-$68.6M
Combined market value
$850.2B
Countries
5

Market values as of .

Largest biotech by earnings
#CompanyEarnings ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health Care$8.5B$210.9B$170.07 1.48% up 32% up United States
2AmgenAMGN · Health Care$7.7B$248.5B$459.50 0.61% down 34% up United States
3BiogenBIIB · Health Care$1.3B$37.1B$251.16 0.19% down 49% up United States
4argenxARGX · Health Care$1.3B$59.6B$947.13 0.40% down 4% up Belgium
5ExelixisEXEL · Health Care$782.6M$16.6B$68.18 1.61% up 57% up United States
6Neurocrine BiosciencesNBIX · Health Care$478.6M$16.8B$165.65 0.21% up 19% up United States
7QiagenQGEN · Health Care$424.9M$10.3B$49.83 0.04% up 12% up Netherlands
8Halozyme TherapeuticsHALO · Health Care$316.9M$10.9B$95.69 0.84% down 38% up United States
9Krystal BiotechKRYS · Health Care$204.8M$8.8B$297.75 0.05% down 46% up United States
10Bio-TechneTECH · Health Care$181.9M$11.4B$72.78 0.01% down 25% up United States
11RepligenRGEN · Health Care$48.9M$10.4B$162.46 0.20% down 6% up United States
12Adaptive BiotechnologiesADPT · Health Care-$59.5M$4.6B$28.50 2.26% up 103% up United States
13Twist BioscienceTWST · Health Care-$77.7M$7.1B$107.74 2.57% up 304% up United States
14CG OncologyCGON · Health Care-$161M$7.1B$79.94 5.71% down 99% up United States
15Kodiak SciencesKOD · Health Care-$230M$6.3B$96.97 3.73% down 424% up United States
16Kymera TherapeuticsKYMR · Health Care-$311.4M$10.4B$122.26 2.85% down 96% up United States
17ImmunityBioIBRX · Health Care-$351.4M$6.5B$6.13 2.42% up 185% up United States
18Scholar Rock HoldingSRRK · Health Care-$377.9M$5.5B$45.11 1.27% up 12% up United States
19ImmunovantIMVT · Health Care-$505.6M$6.9B$33.25 0.09% down 40% up United States
20CRISPR TherapeuticsCRSP · Health Care-$581.6M$3.9B$40.55 0.45% up 24% down Switzerland
21VaxcytePCVX · Health Care-$766.6M$9.5B$60.30 2.13% down 24% up United States
22Revolution MedicinesRVMD · Health Care-$1.1B$35.6B$164.57 1.38% down 136% up United States
23BioNTechBNTX · Health Care-$1.3B$21.1B$85.19 0.08% down 17% down Germany
24ModernaMRNA · Health Care-$2.8B$84B$207.60 3.57% down 764% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which biotech rank first by earnings?

Gilead Sciences ($8.5B), Amgen ($7.7B) and Biogen ($1.3B) are the top three of the 24 biotech ranked by earnings as of 17 Nov 2026, 17:20 UTC.

How many biotech are in this ranking?

24 are ranked by earnings.

What are these biotech worth together?

Their combined market value is $850.2B as of 17 Nov 2026, 17:20 UTC.

What does ranking by earnings measure?

Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.

Cite this page

Funkfolio, “Largest biotech by earnings”, data as of 17 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings

Underlying data: Yahoo Finance; SEC EDGAR.